CIK 0001655759
- Accelerated filer
ARVINAS, INC.
Sign in to watch- Ticker
- ARVN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 472566120
- Phone
- +1 203-535-1456
- Business address
- 395 WINCHESTER AVE, 5 SCIENCE PARK, NEW HAVEN, CT, 06511
- Former names
- ARVINAS INC., ARVINAS HOLDING COMPANY, LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,475
- in 1 filing, $1K under 10b5-1 plans
Net −$1,475. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-02-16 | Houston John G President and CEO | Sale | −600 | $80.25 | $48K | 816,200 |
| 2021-02-16 | Houston John G President and CEO | Exercise or conversion · Stock Option (right to buy) | −44,000 | 88,880 | ||
| 2021-02-16 | Cassidy Sean A Chief Financial Officer | Exercise or conversion | +6,815 | $16.00 | $109K | 161,599 |
| 2021-02-16 | Cassidy Sean A Chief Financial Officer | Exercise or conversion | +35,144 | $16.00 | $562K | 196,743 |
| 2021-02-16 | Cassidy Sean A Chief Financial Officer | Sale | −8,158 | $77.60 | $633K | 188,585 |
| 2021-02-16 | Cassidy Sean A Chief Financial Officer | Sale | −19,303 | $78.61 | $1.5M | 169,282 |
| 2021-02-16 | Cassidy Sean A Chief Financial Officer | Sale | −3,958 | $79.32 | $314K | 165,324 |
| 2021-02-16 | Cassidy Sean A Chief Financial Officer | Sale | −396 | $80.28 | $32K | 164,928 |
| 2021-02-16 | Cassidy Sean A Chief Financial Officer | Sale | −2,793 | $77.62 | $217K | 162,135 |
| 2021-02-16 | Cassidy Sean A Chief Financial Officer | Sale | −6,160 | $78.65 | $484K | 155,975 |
| 2021-02-16 | Cassidy Sean A Chief Financial Officer | Sale | −1,161 | $79.42 | $92K | 154,814 |
| 2021-02-16 | Cassidy Sean A Chief Financial Officer | Sale | −30 | $80.43 | $2K | 154,784 |
| 2021-02-16 | Cassidy Sean A Chief Financial Officer | Exercise or conversion · Stock Option (right to buy) | −6,815 | 0 | ||
| 2021-02-16 | Cassidy Sean A Chief Financial Officer | Exercise or conversion · Stock Option (right to buy) | −35,144 | 46,262 | ||
| 2021-02-16 | Peck Ronald Chief Medical Officer | Exercise or conversion | +20,000 | $26.58 | $532K | 22,754 |
| 2021-02-16 | Peck Ronald Chief Medical Officer | Sale | −20,000 | $77.35 | $1.5M | 2,754 |
| 2021-02-16 | Peck Ronald Chief Medical Officer | Exercise or conversion · Stock Option (right to buy) | −20,000 | 52,184 | ||
| 2020-12-31 | Houston John G President and CEO | Grant or award | +310 | $29.02 | $9K | 818,248 |
| 2020-12-18 | Ratcliffe Liam Director | Purchase | +142,857 | $70.00 | $10.0M | 822,857 |
| 2020-11-09 | Kennedy Edward Moore Jr. Director | Purchase | +8,333 | $23.99 | $200K | 42,718 |
Page 21 of 32 · 628 trades